IV and topical tranexamic acid protocols reduce blood loss and transfusion needs in THA
IV and topical tranexamic acid protocols reduce blood loss and transfusion needs in THA
The Efficacy of Tranexamic Acid in Total Hip Arthroplasty: A Network Meta-analysis
J Arthroplasty. 2018 Oct;33(10):3083-3089.e4. doi: 10.1016/j.arth.2018.06.023Synopsis
Data from 31 randomized controlled trials on blood loss, and from 16 randomized controlled trials on transfusion rate, were included in this network metaanalysis comparing outcome between various tranexamic acid (TXA) administration strategies, including intravenous (IV), intraarticular/topical (IA), and oral TXA, and placebo in patients who underwent total hip arthroplasty. When assessing blood l...
                To view the full content, login to your account,
or start your 30-day FREE Trial today.
            
            FREE TRIAL
            LOGIN
            Forgot Password?
    Explore some of our unlocked ACE Reports below!
 
                Learn about our AI Driven 
 High Impact Search Feature
     
    Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue 
                     
                 
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         
                                                         LOGIN
                                    LOGIN
                                 
             
                        
Join the Conversation
Please Login or Join to leave comments.